bims-caglex Biomed News
on Cellular aging and life extension
Issue of 2026–05–24
two papers selected by
Mario Alexander Guerra Patiño, Universidad Antonio Nariño



  1. Commun Chem. 2026 May 18. pii: 178. [Epub ahead of print]9(1):
      Direct reprogramming (DR) involves inducing cell differentiation by converting somatic cells directly into target cells without bypassing induced pluripotent stem cells. Small molecule-induced DR reduces tumorigenic risk relative to transcription factor-triggered DR. However, identifying small molecules for DR through experimental exploration alone remains challenging. This study presents a computational method, SuperDIRECTEUR, to predict small molecules for DR using single-cell temporal transcriptome data. The cellular conversion processes in DR were simulated by calculating the RNA velocity in each cell. These processes were then classified into multiple stages (i.e., primal, immature, and mature stages), and a variant of simulated annealing was employed to search for the combination of small molecules that mimic stage-specific gene expression patterns during DR. We applied SuperDIRECTEUR to identifying candidate small molecules for DR converting mouse embryonic fibroblasts to induced neurons, and were able to reproduce experimentally verified and functionally related molecules inducing the corresponding conversions in a temporal stage-specific manner. The target proteins of the predicted small molecules in the early and later stages were distinctively involved in biologically relevant pathways toward neuronal differentiation and maturation. The proposed method has potential for practical applications in regenerative medicine.
    DOI:  https://doi.org/10.1038/s42004-026-01991-y
  2. Adv Exp Med Biol. 2026 ;1509 179-216
      Cell fusion has evolved at an exciting pace over the past 50 years. From experimental studies in vitro, later applications in vivo, and various discoveries of innate in vivo cell fusion, this field continues to expand, particularly as biotechnological strategies advance. Initially developed as an experimental approach to study nuclear reprogramming, cell fusion provided some of the first and most convincing evidence that differentiated somatic nuclei are still reprogrammable. Fusion-based systems changed long-held beliefs about the stability of cell fate by demonstrating that significant transcriptional, epigenetic, and chromatin changes can occur within hours. Subsequent in vivo studies demonstrated that similar fusion events occur naturally in adult tissues, principally in response to injury, inflammation, or degenerative stress. In the context of regeneration, cell fusion has emerged as an important and previously under-recognized mechanism underlying cellular plasticity, tissue repair, and functional recovery.In this chapter, we discuss the molecular and cellular mechanisms that control cell fusion, the experimental tools used to study it, and the insights gained from fusion-based models of reprogramming. We further examine the growing evidence supporting the role of cell fusion in tissue regeneration across multiple organs, including the liver, muscle, nervous system, and heart. Finally, we address the challenges, limitations, and safety considerations that currently restrict therapeutic translation and outline future directions for understanding and applying cell fusion in regenerative biology.
    Keywords:  Cell fusion; Polyploidy; Regeneration; Reprogramming
    DOI:  https://doi.org/10.1007/978-3-032-22637-2_8